APP and Alzheimer disease: According to studies conducted in mouse models of AD based on mutations in APP and PS1 genes, both excessive and reduced levels of Ca2+ activity have been observed at the neuronal level, with excessive activity predominating in the early stages of the disease, attributed to soluble Aβ [112,113,114,115].